EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Socioeconomic equality in initiation of biologic treatment in Danish patients with inflammatory bowel disease

Sofie Ronja Petersen, Nathalie Fogh Rasmussen, Agnete Overgaard Donskov, Lau Caspar Thygesen, Kim Rose Olsen, Linda Juel Ahrenfeldt, Vibeke Andersen

Wiener klinische Wochenschrift · 2025

DOI: 10.1007/s00508-024-02376-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wiener klinische Wochenschrift, 2025. Verfasst von Sofie Ronja Petersen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Diagnostic and Clinical Research Unit, University Hospital of Southern Denmark, Kresten Phillipsens vej 15, Aabenraa, Denmark. srpe@rsyd.dk. Hauptthemen laut MEDLINE: Crohn Disease, Healthcare Disparities, Inflammatory Bowel Diseases, Colitis, Ulcerative. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beckett-Fonden, Knud og Edith Eriksens Mindefond, University of Southern Denmark.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Low socioeconomic status is associated with disadvantages in health outcomes and delivery of medical care in patients with Inflammatory Bowel Disease (IBD). Inequality in the utilisation of biologic treatment is largely unexplored.

Aim

To explore the potential association of socioeconomic status and time to first biologic treatment in a population-based IBD cohort.

Methods

All 37,380 IBD incidences between 2000 and 2017 from the Danish National Patient Register were identified and linked to socioeconomic information including educational level, income and occupational status at diagnosis. Hazard ratios for receiving biologic treatment among socioeconomic groups were estimated using Cox proportional hazard regression.

Results

No difference in time between diagnosis and biologic treatment initiation was found comparing patients with upper secondary, vocational, or academic education to those with lower secondary education in patients with IBD. Patients with Crohn’s disease in the two highest income quartiles received biologic treatment earlier (HR 1.16; 95% CI: 1.04; 1.30 & HR 1.15; 95% CI: 1.03; 1.30). An elevated treatment rate was found for persons with “other” occupational status (unspecified source of income) compared to employed persons in patients with ulcerative colitis (HR 1.36; 95% CI: 1.11; 1.66), but not in patients with Crohn’s disease.

Conclusion

This study revealed equal initiation of biologic treatment among patients with IBD across different educational background, income and occupational status. However, results are limited to a setting with free universal healthcare coverage and treatment needs should be considered and addressed in future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseHealthcare DisparitiesInflammatory Bowel DiseasesColitis, UlcerativeBiological TherapyBiological ProductsHumansDenmarkMaleFemaleAdultMiddle AgedYoung AdultRegistriesSocioeconomic FactorsSocial ClassAdolescentAged

Stichwörter der Autor:innen

EducationIncomeInflammatory Bowel DiseaseOccupationTime to treatment

Substanzen

Biological Products

Autor:innen und Institutionen

  • Molecular Diagnostic and Clinical Research Unit, University Hospital of Southern Denmark, Kresten Phillipsens vej 15, Aabenraa, Denmark. srpe@rsyd.dk.
  • Molecular Diagnostic and Clinical Research Unit, University Hospital of Southern Denmark, Kresten Phillipsens vej 15, Aabenraa, Denmark.
  • Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Hospital Pharmacy Research Unit, University Hospital of Southern Denmark, Aabenraa, Denmark.
  • Department of Geriatrics, Hospital of Southern Denmark, Aabenraa, Denmark.
  • National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.

Förderung

  • Beckett-Fonden
  • Knud og Edith Eriksens Mindefond
  • University of Southern Denmark

Zitieren

APA

Petersen, S. R., Fogh Rasmussen, N., Overgaard Donskov, A., Thygesen, L. C., Olsen, K. R., Juel Ahrenfeldt, L., & Andersen, V. (2025). Socioeconomic equality in initiation of biologic treatment in Danish patients with inflammatory bowel disease. Wiener klinische Wochenschrift. https://doi.org/10.1007/s00508-024-02376-8

Vancouver

Petersen SR, Fogh Rasmussen N, Overgaard Donskov A, Thygesen LC, Olsen KR, Juel Ahrenfeldt L, et al. Socioeconomic equality in initiation of biologic treatment in Danish patients with inflammatory bowel disease. Wiener klinische Wochenschrift. 2025. doi:10.1007/s00508-024-02376-8

BibTeX
@article{Petersen2025,
  author = {Petersen, Sofie Ronja and Fogh Rasmussen, Nathalie and Overgaard Donskov, Agnete and Thygesen, Lau Caspar and Olsen, Kim Rose and Juel Ahrenfeldt, Linda and Andersen, Vibeke},
  title = {Socioeconomic equality in initiation of biologic treatment in Danish patients with inflammatory bowel disease},
  journal = {Wiener klinische Wochenschrift},
  year = {2025},
  doi = {10.1007/s00508-024-02376-8}
}
Kostenlos starten →